GlassScriptPhysician profile
Andrea Webb Oates
NPI 1710333133
$9,209.83
in general payments reported to CMS, 2019-2025
69 companies · $2,123 in 2025
The $2,123 reported for 2025 was more than what 94% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $112 · 2022: $1,706 · 2023: $2,779 · 2024: $2,491 · 2025: $2,123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,119 · Education: $274.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,118.85 |
| Education | $273.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $795.34 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $611.52 | 2022-2025 | Calquence, Tagrisso, Enhertu |
| Janssen Biotech, INC. | $594.33 | 2022-2025 | Tecvayli, Darzalex, Erleada |
| Pfizer INC. | $431.48 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $427.93 | 2022-2025 | Keytruda, Lynparza, Welireg |
| Celgene Corporation | $382.03 | 2022-2025 | Reblozyl, Pomalyst, Opdualag |
| Seagen INC. | $342.74 | 2022-2024 | Adcetris, Tukysa, Padcev |
| Astellas Pharma US INC | $303.63 | 2022-2024 | Padcev, Xtandi, Xospata |
| Genentech USA, INC. | $263.65 | 2022-2025 | Polivy, Venclexta, Tecentriq |
| Daiichi Sankyo INC. | $258.55 | 2022-2025 | Injectafer, Enhertu, Datroway |
| Glaxosmithkline, LLC. | $248.82 | 2022-2025 | Zejula, Jemperli, Ojjaara |
| Genzyme Corporation | $231.08 | 2022-2025 | |
| Abbvie INC. | $219.66 | 2022-2025 | |
| Lilly USA, LLC | $197.90 | 2022-2024 | Verzenio, Jaypirca, Retevmo |
| Takeda Pharmaceuticals U.S.A., INC. | $192.10 | 2022-2024 | Fruzaqla, Alunbrig, Ninlaro |
Show all 69 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $173.62 | 2022-2025 | Jakafi, Pemazyre, Monjuvi |
| Emd Serono, INC. | $158.37 | 2023-2025 | Tepmetko, Bavencio |
| Adc Therapeutics America, INC. | $137.82 | 2022-2025 | |
| Array Biopharma INC | $136.20 | 2023-2025 | Mektovi, Braftovi, Tukysa |
| Bayer Healthcare Pharmaceuticals INC. | $134.25 | 2022-2024 | |
| Exelixis INC. | $132.97 | 2022-2025 | Cabometyx |
| Jazz Pharmaceuticals INC. | $131.91 | 2022-2025 | |
| Janssen Scientific Affairs, LLC | $118.73 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $117.97 | 2022-2025 | Opdivo, Eliquis |
| Eisai INC. | $113.31 | 2023-2025 | |
| Novo Nordisk INC | $111.52 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $108.91 | 2022-2025 | Libtayo |
| Ipsen Biopharmaceuticals, INC | $108.80 | 2022-2024 | Somatuline Depot, Onivyde |
| Spectrum Pharmaceuticals INC. | $104.51 | 2023-2025 | Rolvedon |
| Karyopharm Therapeutics INC. | $102.74 | 2022-2025 | Xpovio |
| Deciphera Pharmaceuticals INC. | $101.18 | 2022-2025 | Qinlock, Romvimza |
| Taiho Oncology, INC. | $92.69 | 2022-2025 | |
| Aveo Pharmaceuticals, INC. | $90.29 | 2023-2025 | Fotivda |
| Alexion Pharmaceuticals, INC. | $81.95 | 2022-2024 | Ultomiris |
| G1 Therapeutics, INC. | $80.10 | 2022-2023 | Cosela |
| Janssen Pharmaceuticals, INC | $79.65 | 2022-2024 | Xarelto |
| Beigene USA, INC. | $79.43 | 2022-2024 | Brukinsa |
| Sumitomo Pharma America, INC. | $78.61 | 2023-2025 | Orgovyx |
| Puma Biotechnology, INC. | $77.79 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $77.77 | 2024-2025 | Gilotrif |
| Genmab U.S., INC. | $77.30 | 2022-2025 | Epkinly, Tivdak |
| Servier Pharmaceuticals LLC | $71.14 | 2023-2025 | |
| Rigel Pharmaceuticals, INC. | $68.03 | 2023-2024 | Rezlidhia, Tavalisse |
| Mirati Therapeutics, INC. | $56.45 | 2023-2024 | Krazati |
| Sobi, INC | $51.94 | 2024-2025 | |
| Macrogenics, INC. | $47.43 | 2022-2023 | |
| Cti Biopharma Corp. | $47.37 | 2022-2023 | Vonjo |
| Morphosys, US INC. | $45.90 | 2022-2023 | Monjuvi |
| Immunocore Limited | $44.86 | 2024-2025 | Kimmtrak |
| Blueprint Medicines Corporation | $38.68 | 2022-2024 | Ayvakit |
| Gilead Sciences, INC. | $36.03 | 2023-2024 | Trodelvy |
| Beone Medicines USA, INC. | $32.71 | 2025 | Brukinsa, Tevimbra |
| Eagle Pharmaceuticals, INC. | $32.25 | 2022-2024 | |
| Immunogen, INC. | $31.49 | 2023 | Elahere |
| Springworks Therapeutics, INC. | $29.82 | 2024 | Ogsiveo |
| Genentech, INC. | $25.79 | 2024 | Columvi, Lunsumio |
| Stemline Therapeutics INC. | $25.74 | 2025 | Orserdu |
| Tersera Therapeutics LLC | $24.14 | 2025 | Zoladex |
| Geron Corporation | $23.62 | 2025 | Rytelo |
| Pharmaessentia USA Corporation | $23.45 | 2024 | Besremi |
| Verastem, INC. | $19.77 | 2025 | Avmapki Fakzynja Co-Pack |
| Kyowa Kirin, INC. | $18.03 | 2024 | Poteligeo |
| Epizyme, INC. | $17.28 | 2022 | |
| Myovant Sciences INC. | $17.19 | 2022 | |
| Pharmacyclics LLC, An Abbvie Company | $15.14 | 2022 | |
| Pharmacosmos Therapeutics INC. | $14.79 | 2023 | Monoferric |
| Coherus Oncology, INC. | $14.32 | 2025 | Loqtorzi |
| Helsinn Therapeutics (U.S.), INC. | $13.68 | 2022 | |
| Collegium Pharmaceutical, INC. | $13.64 | 2025 | Jornay Pm |
Drugs and devices associated with these payments
Keytruda $353Kisqali $337Reblozyl $264Tukysa $194Enhertu $169Tecvayli $168Lynparza $163Piqray $162Sarclisa $158Verzenio $149Jaypirca $149Ibrance $140Mektovi $136Padcev $133Orgovyx $133Xtandi $133Darzalex $130Venclexta $124Elahere $124Braftovi $123Cabometyx $121Adcetris $115Calquence $114Lenvima $113Tagrisso $112Zepzelca $109Rolvedon $105Jakafi $103Injectafer $102Erleada $100Jemperli $95.44Zejula $95.44Inlyta $94.90Libtayo $93.64Fotivda $90.29Scemblix $89.89Onivyde $85.71Somatuline Depot $85.71Fabhalta $83.72Welireg $83.57Rybrevant $82.37Brukinsa $81.74Elrexfio $81.70Qinlock $77.64Fruzaqla $72.77Retevmo $70.19Ojjaara $69.47Tavalisse $68.03Rezlidhia $68.03Monjuvi $66.49Lunsumio $65.50Ultomiris $64.14Xarelto $63.53Xpovio $63.43Lonsurf $62.44Inqovi $62.44Talvey $61.71Alunbrig $60.99Polivy $59.83Paxlovid $56.89Krazati $56.45Opdivo $56.25Talzenna $55.71Lorbrena $53.97Pemazyre $52.33Doptelet $51.94Epkinly $51.75Pomalyst $50.71Xospata $47.47Columvi $46.79Tibsovo $46.64Zynlonta $46.56Tecentriq $46.54Bosulif $46.19Besponsa $46.19Xofigo $46.00Nubeqa $46.00Ayvakit $45.92Comirnaty $45.19Kimmtrak $44.86Balversa $41.18Akeega $41.18Xalkori $37.64Tepmetko $36.86Niktimvo $35.14Nerlynx $33.59Vonjo $33.57Eliquis $32.00Promacta $31.94Opdualag $31.80Gilotrif $30.48Ogsiveo $29.82Margenza $28.75Romvimza $28.61Datroway $26.63Orserdu $25.74Voranigo $24.50Zoladex $24.14Stivarga $23.83Vitrakvi $23.83
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrea Oates listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.